STAGE IV UTERINE CORPUS CANCER AJCC V8
Clinical trials for STAGE IV UTERINE CORPUS CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV UTERINE CORPUS CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IV UTERINE CORPUS CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to shrink returning gynecologic tumors
Disease control Recruiting nowThis early-stage study tests a drug called talazoparib together with radiation therapy for people whose gynecologic cancer (like ovarian, endometrial, or cervical) has returned after previous treatment. The main goal is to find the safest dose and see how well the combination wor…
Matched conditions: STAGE IV UTERINE CORPUS CANCER AJCC V8
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 16, 2026 22:48 UTC
-
New drug combo trial hopes to tame tough cancers
Disease control Recruiting nowThis early-phase study tests a new drug called IACS-6274, given alone or with other medicines, in people with advanced solid tumors (like certain melanomas, ovarian, and uterine cancers). The main goal is to find the safest dose and understand side effects. About 54 adults will t…
Matched conditions: STAGE IV UTERINE CORPUS CANCER AJCC V8
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
Electric field device shows promise in taming advanced cancers
Disease control Recruiting nowThis early-phase study tests a wearable device that creates low-intensity electric fields (tumor treating fields) combined with either cabozantinib or a chemo-immunotherapy pair (nab-paclitaxel and atezolizumab) in people with advanced solid tumors in the abdomen or chest. The go…
Matched conditions: STAGE IV UTERINE CORPUS CANCER AJCC V8
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 11, 2026 20:46 UTC
-
Chemo mist shows promise for abdominal cancers in early trial
Disease control Recruiting nowThis early-stage study is testing a new method called PIPAC, which turns chemotherapy into a fine mist and sprays it directly into the abdomen during a keyhole surgery. The goal is to see if this approach is safe and can reduce side effects compared to standard chemotherapy. Abou…
Matched conditions: STAGE IV UTERINE CORPUS CANCER AJCC V8
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 11, 2026 20:39 UTC
-
Tumor tissue study aims to predict cancer treatment success
Knowledge-focused Recruiting nowThis study collects tissue samples from people with various advanced or early-stage cancers to train a new diagnostic platform called Elephas. The goal is to see how accurately it can predict whether a patient will respond to immunotherapy or chemoimmunotherapy. About 324 partici…
Matched conditions: STAGE IV UTERINE CORPUS CANCER AJCC V8
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC